Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era.
Fatola AA, Evans MD, Brown J, Davis E, Johnson AD, Antun AG, Farland A, Woods R, Metjian A, Park Y, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Eubanks S, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JEE, Sridharan M, Go RS, McCrae KR, Upreti HV, Lim MY, Kocher NK, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Mazepa M, Chaturvedi S.
Fatola AA, et al. Among authors: lim my.
Blood Adv. 2024 Dec 3:bloodadvances.2024013313. doi: 10.1182/bloodadvances.2024013313. Online ahead of print.
Blood Adv. 2024.
PMID: 39626301